Conversely, the PPP2R1A low-expression group showed enrichment in fructose and mannose metabolism, hypertrophic cardiomyopathy, and calcium signaling pathway, among others (Fig. 13B). This evidence concerns the gene PPP2R1A and hypertrophic cardiomyopathy.